These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 20303955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protective immunity to amebiasis: new insights and new challenges.
    Stanley SL.
    J Infect Dis; 2001 Aug 15; 184(4):504-6. PubMed ID: 11471109
    [Abstract] [Full Text] [Related]

  • 3. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R, Jarillo-Luna A.
    Parasite Immunol; 2005 Aug 15; 27(1-2):1-8. PubMed ID: 15813717
    [Abstract] [Full Text] [Related]

  • 4. The role of the secretory immune response in the infection by Entamoeba histolytica.
    Carrero JC, Cervantes-Rebolledo C, Aguilar-Díaz H, Díaz-Gallardo MY, Laclette JP, Morales-Montor J.
    Parasite Immunol; 2007 Jul 15; 29(7):331-8. PubMed ID: 17576362
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amebiasis: host-pathogen biology.
    Sepúlveda B.
    Rev Infect Dis; 1982 Jul 15; 4(6):1247-53. PubMed ID: 6296964
    [Abstract] [Full Text] [Related]

  • 9. Role of mucosal secretory immunity in the development of an amebiasis vaccine.
    Ravdin JI, Kelsall BL.
    Am J Trop Med Hyg; 1994 Jul 15; 50(5 Suppl):36-41. PubMed ID: 8203722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity.
    Garcia-Nieto RM, Rico-Mata R, Arias-Negrete S, Avila EE.
    Parasitol Int; 2008 Dec 15; 57(4):417-23. PubMed ID: 18571975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue destruction and invasion by Entamoeba histolytica.
    Ralston KS, Petri WA.
    Trends Parasitol; 2011 Jun 15; 27(6):254-63. PubMed ID: 21440507
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD, Petri WA.
    Eur J Clin Microbiol Infect Dis; 1998 Sep 15; 17(9):601-14. PubMed ID: 9832261
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.